REBECCA KRAFTICK: Open Payments
NPI 1639112402 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 23 payments from 13 companies in 2025. Trend: 2023 $1,126 · 2024 $2,703 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $71 |
| Novo Nordisk Inc | 4 | $69 |
| Amgen Inc. | 3 | $53 |
| PFIZER INC. | 2 | $42 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $35 |
| SCPHARMACEUTICALS INC. | 1 | $24 |
| Abbott Laboratories | 1 | $24 |
| Boston Scientific Corporation | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: LEQVIO, Wegovy, REPATHA, VYNDAQEL, LifeVest, FUROSCIX, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, ENROUTE Transcarotid Neuroprotection System.
Industry payments across KY — which companies pay providers there.
